Variable | Total (N or Mean ± SD) | Kidney Tx recipients (n = 11) | Liver Tx recipients (n = 40) |
---|---|---|---|
Age (years) | 6.72 ± 5.47 | 7.72 ± 4.91 | 6.11 ± 5.80 |
Sex | |||
Male | 33 (64.7) | 4 | 29 |
Female | 18 (35.3) | 7 | 11 |
White blood cells | 8.79 ± 5.57 | 9.01 ± 6.77 | 8.66 ± 5.32 |
Creatinine (mg/dL) | 0.64 ± 1.04 | 0.80 ± 1.00 | 0.61 ± 0.95 |
Aspartate transaminase (U/L) | 161.58 ± 132.52 | 21.39 ± 19.88 | 171.21 ± 134.01 |
Alanine aminotransferase (U/L) | 98.75 ± 80.93 | 14.33 ± 10.00 | 112.67 ± 99.07 |
Total Bilirubin (mg/dL) | 17.96 ± 16.88 | 1.22 ± 1.00 | 19.08 ± 17.23 |
PELD score | 21.20 ± 8.88 | – | 21.20 ± 8.88 |
Patients outcome | |||
Alive | 40 (78.4) | 11 | 29 |
Expired | 11 (21.6) | 0 | 11 |
Immunosuppressive regimen | |||
Tacrolimus + prednisolone | 32(62.74%) | 1 | 31 |
Mycophenolate mofetil + tacrolimus | 9 (17.64%) | 1 | 8 |
Cyclosporine + prednisolone | 10(19.60%) | 9 | 1 |
Induction regimen | |||
Methylprednisolone | 41(80.39%) | 8 | 33 |
Thymoglobulin | 10 (19.6%) | 3 | 7 |
Post-transplant laboratory value | |||
O2 saturation (%) | 91 | 93 | 90 |
Lymphocytopenia | 5 (10.6%) | 2 | 3 |
Lymphocytosis | 13 (27.7%) | 1 | 12 |
Elevated CRP | 19 (51.4%) | 10 | 9 |
Elevated ESR | 8 (22.9%) | 3 | 5 |
Prograf level(ng/dl) | 4.91 ± 2.21 | 5.82 ± 1.99 | 4.88 ± 2.01 |
Cyclosporine level | 190.34 ± 34.12 | 194.00 ± 36.21 | 188.30 ± 30.01 |
CMV PCR positive | 4 (14.8%) | 3 | 1 |